Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

2.5K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.5K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

15.1K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Astragaloside Ⅳ ameliorates cardiac fibroblast injury induced by the radiation bystander effect and modulates the miRNA-134-5p/BDNF/TGF-β1 signaling pathway].

Zhonghua xin xue guan bing za zhi·2026
Same author

[Construction and evaluation of a thrombosis risk prediction model in patients with primary immune thrombocytopenia].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026
Same author

Effects of a diabetes education program integrated with text-message support for lifestyle change among older individuals with type 2 diabetes in communities: a randomised controlled trial.

Public health·2024
Same author

[A case of neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination caused by a variant in NACC1 gene].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2024
Same author

[Efficacy of decitabine in patients with glucocorticoid-resistant primary immune thrombocytopenia: factors influencing treatment responses].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2023
Same author

[Clinical management and prognosis for descending necrotizing mediastinitis].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2023

Related Experiment Video

Updated: Mar 1, 2026

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
04:32

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

8.2K

[Comparative study between two bleeding grading systems of primary immune thrombocytopenia].

S Xiao1, Q Liu, M Hou

  • 1Department of Hematology, Qilu Hospital, Shandong University, Jinan 250012, China.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|June 1, 2017
PubMed
Summary

The Immune Thrombocytopenia (ITP) bleeding scale (version 2016) effectively assesses bleeding in ITP patients, showing good correlation with other tools and responsiveness to treatment. This scale is a valuable clinical tool for managing ITP.

Keywords:
Bleeding scorePlatelet countThrombocytopenia

More Related Videos

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.5K
Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors
14:30

Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors

Published on: August 7, 2021

7.6K

Related Experiment Videos

Last Updated: Mar 1, 2026

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
04:32

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

8.2K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.5K
Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors
14:30

Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors

Published on: August 7, 2021

7.6K

Area of Science:

  • Hematology
  • Clinical Medicine
  • Thrombosis Research

Background:

  • Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low platelet counts and increased bleeding risk.
  • Accurate assessment of bleeding severity is crucial for managing ITP patients and evaluating treatment efficacy.
  • Existing bleeding assessment tools require validation for clinical utility and efficiency.

Purpose of the Study:

  • To prospectively evaluate the clinical significance and utility of the Immune Thrombocytopenia (ITP) bleeding scale (version 2016).
  • To assess the correlation between the ITP bleeding scale and platelet counts, gender, and disease stage.
  • To evaluate the responsiveness and inter-instrument consistency of the ITP bleeding scale compared to the ITP-BAT.

Main Methods:

  • 88 ITP patients were assessed using the ITP bleeding scale (version 2016) and the ITP-specific bleeding assessment tool (ITP-BAT).
  • Correlation analysis was performed between bleeding scores and clinical parameters (platelet count, gender, disease stage).
  • Responsiveness was evaluated in 47 newly diagnosed ITP patients treated with high-dose dexamethasone, assessing scores before and after treatment.

Main Results:

  • The ITP bleeding scale score showed a significant negative correlation with platelet counts (r=-0.515, P<0.001).
  • Gender and disease stage did not significantly influence bleeding scores.
  • The ITP bleeding scale demonstrated excellent agreement with ITP-BAT, showed significant responsiveness to treatment (P<0.001), and was less time-consuming (3 min vs 7 min).

Conclusions:

  • The ITP bleeding scale (version 2016) is a responsive and consistent tool for assessing bleeding in ITP patients.
  • It correlates well with the ITP-BAT and is efficient for clinical application.
  • The scale serves as an effective tool for condition judgment, risk assessment, and efficacy evaluation in ITP management.